These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28400629)

  • 1. Biostatistics Series Module 8: Assessing Risk.
    Hazra A; Gogtay N
    Indian J Dermatol; 2017; 62(2):123-129. PubMed ID: 28400629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental Epidemiology Terminology and Measures: It Really Is All in the Name.
    Vetter TR; Jesser CA
    Anesth Analg; 2017 Dec; 125(6):2146-2151. PubMed ID: 29028741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The number needed to treat (NNT)].
    Richard T; Vanhaeverbeek M; Van Meerhaeghe A
    Rev Med Brux; 2011; 32(5):453-8. PubMed ID: 22165523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The number needed to treat as a measure of effect in the treatment of primary immune thrombocytopenia].
    Vizcaíno G; Vizcaíno-Carruyo J
    Invest Clin; 2012 Mar; 53(1):16-27. PubMed ID: 22524105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of absolute measures of disease risk in comparative research.
    Replogle WH; Johnson WD
    Fam Med; 2007 Jun; 39(6):432-5. PubMed ID: 17549653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The number needed to treat (NNT) and the number needed to harm (NNH)].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
    Citrome L
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.
    Jaeschke R; Guyatt G; Shannon H; Walter S; Cook D; Heddle N
    CMAJ; 1995 Feb; 152(3):351-7. PubMed ID: 7828099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA
    Int J Clin Pract; 2013 May; 67(5):407-11. PubMed ID: 23574101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis.
    Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y
    Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number needed to harm: is it too optimistic?
    Massel D
    Can J Cardiol; 2003 Dec; 19(13):1490-2. PubMed ID: 14760438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number remaining at risk: an adjunct to the number needed to treat.
    Massel D; Cruickshank MK
    Can J Cardiol; 2002 Mar; 18(3):254-8. PubMed ID: 11907613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.
    Sinclair JC; Cook RJ; Guyatt GH; Pauker SG; Cook DJ
    J Clin Epidemiol; 2001 Mar; 54(3):253-62. PubMed ID: 11223323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative vs. absolute measures of benefit and risk: what's the difference?
    Citrome L
    Acta Psychiatr Scand; 2010 Feb; 121(2):94-102. PubMed ID: 19694632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number needed to treat needs an associated odds estimation.
    Aino H; Yanagisawa S; Kamae I
    J Public Health (Oxf); 2004 Mar; 26(1):84-7. PubMed ID: 15044581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine.
    Mancini GB; Schulzer M
    Circulation; 1999 Jan; 99(3):377-83. PubMed ID: 9918524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculating confidence intervals for the number needed to treat.
    Bender R
    Control Clin Trials; 2001 Apr; 22(2):102-10. PubMed ID: 11306148
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.